9 METERS BIOPHARMA, INC. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2017 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
9 Meters Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2017 to Q1 2023.
  • 9 Meters Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$12.3M.
  • 9 Meters Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $19.9M, a 51.5% decline from 2021.
  • 9 Meters Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $41.1M, a 26.5% decline from 2020.
  • 9 Meters Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $55.9M, a 232% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$12.3M -$12.3M Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $0 -$6.87M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $6.87M +$6.17M +872% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $707K -$9.3M -92.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $10M -$9.52M -48.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q1 2018 $19.5M +$19M +3296% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $575K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.